-
The conditions of submission
Open access license, copyright, and charges
For submission, the authors are required to sign an exclusive license form for open access publication of their work in the journal under the Creative Commons license 4.0 (CC-BY). The authors retain the copyright to their work. Please see our open access and copyright policy and license agreement for more information.
Currently, there are no submission or page or processing charges applicable to the articles submitted to or published in BioMed RB.
Cover letter
A cover letter (signed by corresponding author on behalf of all authors) is necessary for submissions and implies following conditions:
- The submission has not already published and is not under consideration for publication elsewhere.
- The integrity of submission has been reviewed and confirmed by all authors by knowing that, they are accountable for all aspects of manuscript accuracy on the basis of ICMJE criteria.
Preparing the submission
Original article
Original or research article obtaining from finding of research, includes studies that explain all related information and evidence. The systematic review and meta-analysis articles are also fall in this category. Use following order to prepare the manuscript: A Title page, an Abstract (up to 250 words), Key words, Introduction, Methods, Results, Discussion, Conclusion, Acknowledgments, references, Tables, Figures caption, and supplementary files (If any). Optionally, the conclusion can be combined with discussion section. (maximum ~8000 words, including tables, figures and references).
Review and Mini-Review Article
A full-length review article gives a comprehensive overview and Mini- Review provides concise summary of previously published researches relevant to biomedical disciplines. Use following order to prepare the manuscript: A Title page, an Abstract, Key words, introduction, subtitles in the manuscript as needed, Concluding remark, Acknowledgments, References, Tables, Figures caption, and supplementary files (If any). (maximum ~8000 words for A full-length review and 3000 words for Mini-review articles, including tables, figures and references (50-100)).
Case Reports
Case Reports include scientific reports for description of symptoms and signs of unusual or novel diseases and these conditions follow-up and probable treatments. In this type of article, the patient's information should not be published and if possible, a consent letter should be received from the patient. Use the following order to prepare the manuscript: A Title page, an Abstract, Keywords, an introduction, a case description, a discussion, a conclusion, Acknowledgments, References, Tables, Figures caption, and supplementary files (If any).
Letter
Comments or concerns on particular subjects, either in general or in relation to subjects published in the journal. In addition, novel or additional findings related to the original nature. Use the following order to prepare the manuscript: A Title, Text, and References.
Editorial
An editorial is a statement of opinion written by the publisher or senior editorial staff. Editorials may represent the journal's viewpoint.
Title page
Title
A concise and informative title that avoids long systematic names and complicated chemical formulas as much as possible. Proper nouns and the first word must be capitalized.
Names of Authors
Full names for all the authors should be listed with numbers for the affiliations. Where the last name may be ambiguous (for example, a double name), please specify this clearly.
Affiliation
The affiliation of all authors should be given and identified by the transcript number before the address (eg, 1 faculty …..).
Running Title
A very short running title should be given (up to 50 characters including spaces).
Corresponding author
The responsible author of the article must be marked with an asterisk. The full address, phone and fax number (with country and region code) and email of the corresponding author(s) must be given.
Abstract
The structure of the abstract should not be more than 250 words. For original articles and systematic reviews and meta-analyses, it should concisely describe the background, Methods, Results, and Conclusion. For case reports, it should concisely describe the background, case, and conclusion. Narrative reviews, only includes the background and conclusion.
Keywords
Please provide three to five keywords.
Introduction
The introduction section should clearly and concisely provide the background of the topic with relevant sources. The last paragraph of the introduction should be about the purpose of the topic.
Materials and methods
This section should be divided into sub-titles and contain sufficient details. In the materials and methods section, the name of the manufacturer and the catalog number of all the purchased reagents and consumables must be mentioned. Source of experimental and control animals, including whether they are littermates and/or housemates. The number and gender of the tested animals in different groups should be mentioned. For monoclonal antibodies, the name of the clone should be mentioned. For animal and human results, the ethical approval code should be reported. This journal uses UK/US spelling. The spelling of accepted articles is converted during the production process. Instead of a footnote, the content should be included in the text as a parenthetical topic.
Results
The results should be presented in a clear, descriptive and concise manner with reference to tables, figures and images if necessary. The same data should not be presented in more than one figure. Emphasis should be placed on the new and possible findings of the study as well as any conclusions that can be drawn.
Discussion and Conclusion
Discussion and conclusion are placed in one section. The discussion should compare the present data with previous findings. Limitations of experimental methods should be pointed out, as well as implications for future research. New hypotheses and clinical recommendations are appropriate and should be clearly identified. Recommendations, especially clinical recommendations, may be included where appropriate. The main question of the work should be stated very briefly, and the final conclusion of the study may be presented in a short "conclusion" section, which may stand alone or be a subsection of a discussion or results and discussion section(s).
Tables
The tables should be included at the end of the main text.
Acknowledgments
The acknowledgment section should be contributing the other coauthors who didn’t write in title page.All sources of funding should be declared in this section.
Author contributions
All authors must describe their contribution to the research. Examples of contributions include performing experiments, collecting data, data or analysis tools, providing key/unique reagents, analyzing data, interpreting data, conceiving and designing the study, supervising the study, writing the article, and approving the final version of the manuscript. This section should be according to the Journal policy.
References:
- The BioMed RBreferences style is Vancouver style.
- Reference numbers should not be cited in parentheses or brackets.
- Two references are cited with a comma. Three or more consecutive references are cited in a range with dashes.
- For a citation with two authors, the & should be used in surnames.
- For three or more authors, the “et all” should be followed after the first author’s surname
- References in tables and figures should be in numerical order according to where the item is first cited in the text.
- The references should be listed at the end of the manuscript.
- Only one publication can be listed for each number.
Examples:
Journal article:
1. Zakeri-Milani P, Barzegar-Jalali M, Azimi M, Valizadeh H. Biopharmaceutical classification of drugs using intrinsic dissolution rate (IDR) and rat intestinal permeability. Eur J Pharm Biopharm. 2009;73(1):102-106. doi: 10.1016/j.ejpb.2009.04.015
2. Mohammadi S, Shahbazi-Mojarrad J, Zakeri-Milani P, Shirani A, Farkhani SM, Samadi N, et al. Synthesis and in vitro evaluation of amphiphilic peptides and their nanostructured conjugates. Adv Pharm Bull. 2015;5(1):41-49. doi: 10.5681/apb.2015.006
Online database:
3. Note for Guidance on the Investigation of Bioavailability and Bioequivalence. European Agency for Evaluation of Medicinal Products, Committee for Proprietary Medicinal Products, https://www.ema.europa.eu/en/documents/scientific-guideline/draft-note-guidance-investigation-bioavailability-bioequivalence_en.pdf. Accessed 20 May 2020.
Book:
4. Goodman LS, Gilman A, Brunton LL. Goodman & Gilman's manual of pharmacology and therapeutics. New York: McGraw-Hill Medical; 2008.
5. Miller JC, Miller JN. Statistics for Analytical Chemistery. 3rd ed. Chichester, UK: Ellis Horwood Ltd; 1993.
6. Rowe RC, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipients. 5th ed. London: Pharmaceutical Press; 2006.
Book section:
7. De Jaeghere F, Doelker E, Gurny R. Nanoparticles. In: Mathiowitz E, editor. The Encyclopedia of Controlled Drug Delivery. New York: Wiley and Sons Inc; 1999. P. 641-664.
Conference Proceeding:
8. Dermentzoglou LC, Fleisher D, J.B. D. Dissolution and transit effects on absorption of nonsteroidal anti-inflammatory drugs: a mixing tank approach. Paper presented at: AAPS 1st National Meeting1986 Nov; Washington, D.C.
Figures
The instruction of figures should be followed below protocols.
- Figures must be cited within the main text in numerical order(Figure 1,2)
- Figures should be submitted as separate files via the submission system.
- A legend for each figure should be provided during submission.
- Multi-panel figures (with labeled parts as a, b, c, d, etc.) must be combined.
- According to policy, any specific patient/hospital details should be removed or blacked out (for example, X-rays, MRI scans, etc.).
- According to policy. If photographs of patients are used, they should not be identifiable.
- Original data of the submitted figures should be available, as the editors may request to see these.
- Avoid using touch-up tools, such as cloning and healing tools in Photoshop, or any feature that deliberately obscures manipulations.
Figure Legends
All legends must report a short descriptive sentence of the data contained in the figure. This sentence should be written in bolded font.
File Format:
The Journal of Biomedical Research Bulletin accepted Office word (doc and docx) format.
Additional files
Just The Figures and movies can be added as an additional file. The Figures should be JPEG or TIF format and they should not be more than ….. MB.
General Style Points
The following points suggest the formatting and style.
- Abbreviations: In general, terms should not be abbreviated unless they are used repeatedly and the abbreviation is helpful to the reader. Initially, use the word in full, followed by the abbreviation in parentheses.
- Units of measurement: Measurements should be showed SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
- Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (5 cats, 6 dogs).
- Trade Names: Chemical substances should be referred to by the generic name only. Trade names should not be used. Drugs should be referred to by their generic names. If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.
- Chemical names: Give the chemical name of a compound after the first use of its trivial name. The trivial name may follow throughout the article.
Finalizing submission
Approving the submission proof (PDF) is required before completing the process. After approving the submit bottom is finalize the submition.
Revising the submission
Any subsequent revisions to the submission upon request from the editor will have to follow the same guidelines presented here.